Description

Syndopa CR (250mg) Tablet is a combination medication containing Levodopa and Carbidopa. Levodopa is converted into dopamine in the brain, which helps to alleviate the symptoms of Parkinson’s disease. Additionally, Carbidopa enhances the effects of Levodopa by preventing its breakdown outside the brain. This medicine is primarily used to manage the symptoms of Parkinson’s disease, such as tremors, stiffness, and difficulty with movement. Syndopa CR (250mg) Tablet is specifically formulated as a controlled-release tablet, providing a steady release of the medication over an extended period. This ensures consistent and sustained relief from symptoms throughout the day, allowing for better management of the condition. Regular monitoring by a physician is also recommended to ensure the medication’s effectiveness and prevent any potential side effects.

Additional information